DelveInsight’s, “Chemotherapy-induced Peripheral Neuropathy Pipeline Insight 2025” report provides comprehensive insights about 4+ companies and 5+ pipeline drugs in Chemotherapy-induced ...

Peripheral neuropathy damages peripheral nerves, causing numbness, tingling, and weakness, often starting in the feet and ...

Chemotherapy-Induced Peripheral Neuropathy Pipeline Report covers a complete clinical trials analysis of 15+ drugs and 15+ companies, which are developing therapies to change the treatment outlook.

Rise in peripheral neuropathy cases, the increased prevalence of chronic illnesses, and increasing number of pipeline drugs are some of the key factors driving Peripheral Neuropathy market revenue ...

Dr. Evan Norum, DC, BCN, founder of Advantage Neuropathy, joins us on The Morning Blend to discuss treatments for neuropathy.

Diabetic Peripheral Neuropathy Drugs Uptake Suzetrigine (VX-548), under development by Vertex Pharmaceuticals, holds promise as a potential game-changer in the treatment landscape of diabetic ...

Peripheral neuropathy affects millions, often leaving people feeling frustrated, dismissed, and stuck with symptoms like ...

Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a frequent, dose-dependent complication of anticancer drugs, including platinums, taxanes, epothilones, vinca alkaloids, and newer agents, such ...

PHOENIX, Arizona — In the difficult challenge of treating peripheral neuropathy, a novel approach combining injections of local anesthesia with electronic signal treatment shows improved ...

A 60-year-old man born in Canada was referred to our clinic because of arthritis, a progressive maculopapular rash and severe peripheral neuropathy. He had a history of hypothyroidism and hypogonadism ...